Literature DB >> 10391097

N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells.

A Miyajima1, J Nakashima, M Tachibana, K Nakamura, M Hayakawa, M Murai.   

Abstract

We previously demonstrated a role of reactive oxygen species (ROS) in cytotoxicity induced by cis-dichlorodiammineplatinum (CDDP) in combination with glutathione (GSH) depletors in bladder cancer cells. However, the relationship between CDDP and ROS is still unclear, although many mechanisms of drug resistance have been well characterized. The present study was undertaken to investigate the effects of N-acetylcysteine (NAC), a GSH precursor, on the CDDP-induced effects in bladder cancer cells (KU1). The cytotoxic effects of CDDP were significantly blunted by NAC (1 mM) in KU1 cells. The IC50 of CDDP only (10.2+/-1.2 microM) is significantly lower than that of CDDP with NAC (IC50: 20.3+/-1.6 microM) in KU1 cells. NAC also significantly increased the intracellular concentration of GSH in KU1 cells (37.2+/-1.6 nmol/10(6) cells), compared to controls (15.9+/-7.6 nmol/10(6) cells). While CDDP produced a significant increase in ROS as measured in terms of dichlorofluorescein (DCF) production in KU1 cells in a time-dependent manner, pretreatment with NAC significantly reduced CDDP-induced intracellular DCF in KU1 cells. Moreover, TdT-mediated dUTP-biotin nick-end labeling (TUNEL) assay showed that CDDP-induced apoptosis (31.1+/-3.8%) was significantly inhibited by pretreatment with NAC in KU1 cells (11.2+/-2.6%). These results demonstrated that NAC scavenges CDDP-induced ROS and inhibits CDDP-induced cytotoxicity, suggesting that ROS mediate the CDDP-induced cytotoxicity in bladder cancer cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391097      PMCID: PMC5926102          DOI: 10.1111/j.1349-7006.1999.tb00784.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  23 in total

1.  Intracellular hydroxyl radical production induced by recombinant human tumor necrosis factor and its implication in the killing of tumor cells in vitro.

Authors:  N Yamauchi; H Kuriyama; N Watanabe; H Neda; M Maeda; Y Niitsu
Journal:  Cancer Res       Date:  1989-04-01       Impact factor: 12.701

2.  N-acetylcysteine inhibits apoptosis and decreases viral particles in HIV-chronically infected U937 cells.

Authors:  W Malorni; R Rivabene; M T Santini; G Donelli
Journal:  FEBS Lett       Date:  1993-07-19       Impact factor: 4.124

Review 3.  Mitochondrial changes associated with glutathione deficiency.

Authors:  A Meister
Journal:  Biochim Biophys Acta       Date:  1995-05-24

4.  Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes.

Authors:  D L Evans; C Dive
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

Review 5.  N-acetylcysteine in experimental and clinical acute lung injury.

Authors:  G R Bernard
Journal:  Am J Med       Date:  1991-09-30       Impact factor: 4.965

6.  N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia.

Authors:  K Fukuzawa; S Emre; O Senyuz; K Acarli; M E Schwartz; C M Miller
Journal:  Transplantation       Date:  1995-01-15       Impact factor: 4.939

7.  Failure of N-acetylcysteine to protect against cis-dichlorodiammineplatinum(II)-induced hematopoietic toxicity in mice.

Authors:  R Lerza; G Bogliolo; C Muzzulini; I Pannacciulli
Journal:  Life Sci       Date:  1986-05-12       Impact factor: 5.037

8.  Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation.

Authors:  K Schulze-Osthoff; A C Bakker; B Vanhaesebroeck; R Beyaert; W A Jacob; W Fiers
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

9.  Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.

Authors:  L F Prescott; R N Illingworth; J A Critchley; M J Stewart; R D Adam; A T Proudfoot
Journal:  Br Med J       Date:  1979-11-03

10.  The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.

Authors:  C Meijer; N H Mulder; G A Hospers; D R Uges; E G de Vries
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

View more
  5 in total

Review 1.  Utility of acetylcysteine in treating poisonings and adverse drug reactions.

Authors:  P A Chyka; A Y Butler; B J Holliman; M I Herman
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 2.  Natural products as a means of overcoming cisplatin chemoresistance in bladder cancer.

Authors:  Ganeshkumar Rajendran; John A Taylor; Benjamin L Woolbright
Journal:  Cancer Drug Resist       Date:  2021-03-19

3.  Chronic low vitamin intake potentiates cisplatin-induced intestinal epithelial cell apoptosis in WNIN rats.

Authors:  Bodiga Vijayalakshmi; Boindala Sesikeran; Putcha Udaykumar; Subramaniam Kalyanasundaram; Manchala Raghunath
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

4.  Compensatory combination of romidepsin with gemcitabine and cisplatin to effectively and safely control urothelial carcinoma.

Authors:  Pawat Pattarawat; Tian Hong; Shelby Wallace; Yanchun Hu; Robert Donnell; Tzu-Hao Wang; Chia-Lung Tsai; Jinquan Wang; Hwa-Chain Robert Wang
Journal:  Br J Cancer       Date:  2020-05-11       Impact factor: 7.640

Review 5.  Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity - Exploring the armoury of obscurity.

Authors:  Kanchanlata Singh; Mustansir Bhori; Yasar Arfat Kasu; Ganapathi Bhat; Thankamani Marar
Journal:  Saudi Pharm J       Date:  2017-12-19       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.